Cambridge, MA, United States of America

Zalicus, Inc.


USPTO Granted Patents = 5

% Expired Patents = 80.0


Forward Citations = 72

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Alexis Borisy (2 out of 14 patents)

silverMedal Michael Andrew Foley (2 out of 14 patents)

bronzeMedal Todd W Chappell (2 out of 2 patents)

4.  M James Nichols (2 out of 3 patents)

5.  Daniel S Grau (2 out of 2 patents)

6.  Curtis Keith (2 out of 11 patents)

7.  Grant R Zimmermann (2 out of 6 patents)

8.  Edward Roydon Jost-Price (2 out of 7 patents)

9.  Nicole Hurst (2 out of 6 patents)

10.  Palaniyandi Manivasakam (2 out of 8 patents)

11.  Lisa M Johansen (1 out of 1 patent)

12.  Joseph Lehár (1 out of 1 patent)

13.  Benjamin G Hoffstrom (1 out of 1 patent)

14.  Andrea R Stossel (1 out of 1 patent)

15.  Michael S Slavonic (1 out of 2 patents)


5 patents:

Company Overview
Zalicus, Inc. is a biopharmaceutical company focused on the development of novel treatments for pain and inflammation. The company's lead product candidate, Z944, is currently in clinical trials for the treatment of neuropathic pain. Zalicus is dedicated to improving the lives of patients through innovative drug discovery and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#368 in Cambridge, MA

#2,894 in Massachusetts

#51,620 in US

Cambridge, MA (US)
Cambridge, MA, United States of America
Forward Citations = 72

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Zalicus, Inc.. Retrieved from https://idiyas.com/company/zalicus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…